seen from Germany
seen from China
seen from Russia
seen from Germany
seen from Netherlands
seen from Singapore
seen from France
seen from Malaysia
seen from France
seen from Russia
seen from Malaysia
seen from Italy
seen from China
seen from United States
seen from United States
seen from Russia
seen from Malaysia
seen from Singapore
seen from Malaysia
seen from Malaysia
Tagrisso: The New Horizon in Lung Cancer Treatment
Lung Cancer Pill Shows 'Earth-Shattering' Results in 5-year Study: 'An Optimistic Time'
Discover the latest news on a potentially life-saving medication for lung cancer patients – Tagrisso. Learn how this groundbreaking therapy offers hope by reducing the risk of recurrence and improving survival rates.
Tuesday February 2nd 2.2.2021 Rising trend of young celebrities passing from cancer. Colon cancer and now lung cancer caught at late stages seems such a shame.
At 44, Dustin Diamond, for whom the Bell tolled on Monday 2.1.21, played the roll of Samuel Screech Powers on the teenage staple “Saved by the Bell.” He took his first round of chemotherapy recently and passed soon after. It turns out that the chemo fatally toxic side effects to his “treatment” may very well be what killed him.
Take a look at the serious side effects of one drug used for lung cancer treatment called Tagrisso. Fatal effects of the lungs and heart.
The lungs having to do with keywords and themes of 2020 virus like, ventilators, respiration, breathing, inspiration, exhalation, and pneumonia. The running theme of Corona, Covid-19, Protests, Police brutality, and Capitol insurrection. CAPS was Event 201 syndrome predicted by simulation on 18th of October, 2019.
Osimertinib 80mg Tablet Price, AZD9291
What does Osimertinib (AZD9291) mean?
Osimertinib is a drug salt used to develop anti-cancer medication for the treatment of locally advanced or metastatic non-small-cell lung cancer (NSCLC) and certain other tumor cases. It is also available in the market by its international brand name Tagrisso which is an AstraZeneca Pharmaceuticals product. It is also known by its chemical name AZD9291 and was previously known as Mereletinib.
What are the uses of Osimertinib?
It is an anti-cancer medication used to treat locally advanced or metastatic non-small cell lung cancer (NSCLC), and many other cancer cases.
What are the forms & strengths of Tagrix?
It is available in 40mg & 80mg power tablet form for oral use.
Osimertinib Tablet Brands and their respective manufacturers
All brands come in the form of 40 mg and 80 mg power tablets. Few available brands are and their manufactures are as follows:
Tagrix by Beacon Pharmaceuticals.
Osicent by Incepta Pharmaceuticals.
Tagrisso by AstraZeneca Pharmaceuticals.
Osim by Caprane Pharmaceutical Pvt. Ltd.
Osimert by Everest Pharma.
TagAsso by Asso Pharmaceuticals.
Luciosim by Lucius Pharma.
Irmukin by Genvio Pharma Limited.
Above all and many more.
How to take Osimertinib tablets?
It is available in the form of tablets, so, as recommended by the doctor, it is taken orally by ingesting it with the aid of water and dosage as much as prescribed.
How does Tagrisso 80mg work?
By growing their proliferation in other parts of the body, immune cells have the ability to transform healthy cells into dead cells. Thus, Osimertinib joins the cancer cells and reduces their improved potential. It doesn't make them do any harm or spread further.
Osimertinib side-effects
Following are a couple of adverse post effects reported in patients receiving Osimertinib (AZD9291) tablets:
Diarrhea
Rashes
Mouth sores
Tiredness
Stomatitis
Dry & Itchy Skin
Toenails skin
Low neutrophil counts.
Low platelet count
Low white blood cell counts (leukocyte).
Interstitial lung disease and so on.
All post-effects are not listed above, so after taking Osimertinib tablets, if you feel any of the above or any other related changes in your/patient body, then visit the doctor promptly and let him/her know about it.
Best place to Buy Osimertinib tablets brands online at wholesale price.
MedsDots.net, a true Indian pharmacy is the wholesale supplier of both non-generic & generic Tagrisso tablet and its alternate relative brands as well as other rare and targeted life-saving medicines too.
Why MedsDots.net?
We are a leading and trustworthy provider of medication around the world, and since every customer needs the best, we have confidence in faith and loyalty to the consistency of the substance. Our few main features are as follows:-
100% quality assured.
Indian as well as overseas medical supplier.
Trustworthy in quality of products as well in prices of the products too.
Quickest delivery pledge around 150+ countries at your doorstep.
More than 10000000+ satisfied customers.
Serve rare and targeted life-saving quality medicines
Countries where we shipped.
MedsDots serves its services successfully around worldwide countries including the USA, China, HongKong, Australia, UK, Jordan, Saudi, Malaysia, UAE, Singapore, Ukraine, Russia, Vietnam, Philippines, Poland, Romania, Hungary, Taiwan, New Zealand, and almost anywhere in the world.
How to connect MedsDots?
Visit our official website MedsDots.net for any relevant queries, Call/WhatsApp/Viber on +91–9953810074, text on Wechat/DingTalk:- MedsDots, Skype: medsdotss, QQ no: 3232648085, and you can also write us at [email protected].
MSL DAILY PHARMA NEWS - New drugs make headway against lung, prostate, colon cancers #lungcancer #prostatecancer #coloncancer #Astrazeneca #tagrisso “Doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come back and make treatment simpler and easier to bear. Rather than chemo's imprecise cell-killing approach, Tagrisso targets a specific gene mutation. Its side effects are manageable enough that it can be used for several years to help prevent recurrence, doctors said.” Free webinar on “how to become an MSL” https://lnkd.in/gFYBJ2G Or click on our profile. Click below to read further, like and share it and follow us to learn more. Our MSL testimonials: Http://https://lnkd.in/eEfHu4c https://www.instagram.com/p/CBDH4N7jzXZ/?igshid=hml6thu9vekz
TAGRISSO 80MG|OSIMERITINIB 80MG|MHP
DESCRIPTION
Tagrisso 80mg
A Tagrisso 80mg tablet is containing an active substance known as Osimeritinib, which is formerly known as Mereletinib.
Tagrisso 80mg is considered as third generation medicine, which is available in tablet form.
Tagrisso 80mg is an inevitable, selectively deviated epidermal growth factor receptor prohibitor, containing anti-cancer activity.
The pharmacological category of Tagrisso 80mg tablet is tyrosine kinase prohibitor.
INDICATION
Tagrisso 80mg
A Tagrisso 80mg tablet is widely indicated as first line therapy for advanced non-small cell lung cancer with EGFR mutation positive patients.
Tagrisso 80mg tablet is also used for the treatment of patients affected with advanced EGFR T792M mutation positive NSCLC, disease has advanced on or after the tyrosine kinase inhibitor treatment.
MECHANISM OF ACTION
Tagrisso 80mg
PROPERTIES
Ingredients : Bevacizumab
Strength : 100mg/4ml
Package : 400mg of Bevacizumab containing vial
ADME PROPERTIES
Absorption :
High plasma concentration time of Osimeritinib reaches within 6 hours
Distribution :
Volume of distribution 918L
Human Plasma protein bound to Osimeritinib is 95%
Metabolism :
The metabolism of Osimeritinib is occurs via oxidation.
The Two pharmacologically active metabolite of Osimeritinib are AZ7550 & AZ5104
Excretion :
The mean terminal half-life period 48 hours
Clearance value 14.3L/hr
68% of metabolite is excreted in feces; 14% through urine
2% of unchanged form of drug is eliminated
DOSAGE MANAGEMENT
The recommended dosage of Tagrisso 80mg tablets are, 80mg tablet should be taken as a single dose.
Tagrisso tablet should be administered with or without food.
If patient felt difficult to swallow the Tagrisso tablets as such, must disperse the tablet in 60ml of noncarbonated water and drink the solution immediately.
Tagrisso tablet do not break, crush or chew.
Interrupt the treatment during the conditions like;
Interstitial lung disease
QT prolongation
Symptomatic congestive heart failure
In pain management
Grade III or severe: discontinue the Tagrisso tablet for 3 weeks
Grade 0 to II: follow at 80mg or 40mg as a single dose
If no development in 3 weeks: Discontinue the therapy.
While co administration of Tagrisso with CYP3A4 inducers, the dosage of Tagrisso 80mg should be increased to 160mg as a single dose and followed by 80mg for 3 weeks after discontinuation of strong CYP3A4 inducers.
PRECAUTIONS
Interstitial lung disease:
Tagrisso 80mg
To avoid this problem, withheld or stop the Tagrisso 80mg tablets.
Keratitis:
Tagrisso 80mg
check the manifestation of keratitis regularly and provide supportive measures
Embryo fetal toxicity:
Tagrisso 80mg
Tagrisso 80mg tablet required in pregnancy period causes fetal damage.
QTc extension:
Do not concurrent use of Tagrisso 80mg with drug prolong the QTc
Cardiomyopathy:
Tagrisso 80mg
Periodic cardiac monitoring is assessed; in this condition stop the therapy.
SIDE EFFECTS
The most common adverse effects occurred during the therapy;
Cardiomyopathy, QT prolongation, Interstitial lung disease, Keratitis.
Other common side effect :
Diarrhea or constipation, Hyperglycemia, Hypomagnesemia, Hyponatremia, Elevation of AST & ALT, Stomatitis, Nausea, Vomiting, Rash, Nail toxicity, Pruritus, Dry skin, Headache, Cough, Dyspnea, Fatigue, Pyrexia, Loss of appetite, Respiratory tract infection, Lymphopenia, Thrombocytopenia, Anemia, Neutropenia.
PREGNANCY
Pregnancy category of Osimeritinib is not designate
While using Tagrisso 80mg tablet causes possible for fetal harm.
LACTATION
Milk feeding should not be taken during lactation period.
STORAGE
The Tagrisso 80mg tablet is, stored at 25°C.
Keep the tablet carton from moisture, heat and light.
MISSED DOSE
In case of missed dose, do not take the missed dose and follow the regular dosing schedule.
CONTACT US
PHONE NO:+91-9940472902 EMAIL :[email protected] WEBSITE :
https://millionpharma.com/osimeritinib-80mg.php
TAGRISSO 40MG [OSIMERITINIB 40MG]
DESCRIPTION
Tagrisso 40mg
A Tagrisso 40mg tablet is containing an active substance known as Osimeritinib, which is formerly known as Mereletinib.
Tagrisso 40mg is considered as third generation medicine, which is available in tablet form.
Tagrisso 40mg is an inevitable, selectively deviated epidermal growth factor receptor prohibitor, containing anti-cancer activity.
The pharmacological category of Tagrisso 40mg is tyrosine kinase prohibitor.
INDICATION
Tagrisso 40mg
A Tagrisso 40mg tablet is widely indicated as first line therapy for advanced non-small cell lung cancer with EGFR mutation positive patients.
Tagrisso 40mg is also used for the treatment of patients affected with advanced EGFR T792M mutation positive NSCLC, disease has advanced on or after the tyrosine kinase inhibitor treatment.
MECHANISM OF ACTION
Tagrisso 40mg
Osimeritinib is similar in action when compared to other tyrosine kinase inhibitor drugs.
Osimeritinib is named tyrosine kinase inhibitor of epidermal development factor receptor which is available on the surface of tumor cells
Osimeritinib is non-reversibly converge with mutant type of EGFR at 9 folds than wild sort
Forbids EGFR sharpening changes exon 19 Del and L858R
Prompts denies transformed EGFR with T790M opposition transformation
At last, bring down action against wild kind EGFR
Tagrisso 40mg
PROPERTIES
Ingredients : Osimeritinib
Strength : 40mg
Package : 30 tablets in a carton
ADME
Absorption :
High plasma concentration time of Osimeritinib reaches within 6 hours
Distribution :
Volume of distribution 918L
Human Plasma protein bound to Osimeritinib is 95%
Metabolism :
The metabolism of Osimeritinib is occurs via oxidation.
The Two pharmacologically active metabolite of Osimeritinib are AZ7550 & AZ5104
Excretion :
The mean terminal half-life period 48 hours
Clearance value 14.3L/hr
68% of metabolite is excreted in feces; 14% through urine
2% of unchanged form of drug is eliminated
DOSAGE MANAGEMENT
The recommended dosage of Tagrisso tablet are, 80mg tablet should be taken as a single dose.
Tagrisso 40mg tablet should be administered with or without food.
If patient felt difficult to swallow the Tagrisso tablets as such, must disperse the tablet in 60ml of noncarbonated water and drink the solution immediately.
Tagrisso tablet do not break, crush or chew.
Interrupt the treatment during the conditions like;
Interstitial lung disease
QT prolongation
Symptomatic congestive heart failure
In pain management
Grade III or severe: discontinue the Tagrisso 40mg tablet for 3 weeks
Grade 0 to II: follow at 80mg or 40mg as a single dose
If no development in 3 weeks: Discontinue the therapy.
While co administration of Tagrisso with CYP3A4 inducers, the dosage of Tagrisso should be increased to 160mg as a single dose and followed by 80mg for 3 weeks after discontinuation of strong CYP3A4 inducers.
PRECAUTIONS
nterstitial lung disease:
To avoid this problem, withheld or stop the Tagrisso 40mg tablets.
Keratitis:
check the manifestation of keratitis regularly and provide supportive measures
Embryo fetal toxicity:
Tagrisso 40mg tablet required in pregnancy period causes fetal damage.
QTc extension:
Do not concurrent use of Tagrisso 40mg with drug prolong the QTc
Cardiomyopathy:
Periodic cardiac monitoring is assessed; in this condition stop the therapy.
SIDE EFFECTS
Tagrisso 40mg
The most common adverse effects occurred during the therapy;
Cardiomyopathy, QT prolongation, Interstitial lung disease, Keratitis.
Other common side effect :
Tagrisso 40mg
Diarrhea or constipation, Hyperglycemia, Hypomagnesemia, Hyponatremia, Elevation of AST & ALT, Stomatitis, Nausea, Vomiting, Rash, Nail toxicity, Pruritus, Dry skin, Headache, Cough, Dyspnea, Fatigue, Pyrexia, Loss of appetite, Respiratory tract infection, Lymphopenia,Thrombocytopenia, Anemia, Neutropenia.
PREGNANCY
Pregnancy category of Osimeritinib is not designate
While using Tagrisso 40mg tablet causes possible for fetal harm
LACTATION
Milk feeding should not be taken during lactation period.
STORAGE
The Tagrisso 40mg tablet is, stored at 25°C.
Keep the tablet carton from moisture, heat and light.
MISSED DOSE
In case of missed dose, do not take the missed dose and follow the regular dosing schedule.
CONTACT US
PHONE NO: +91-9940472902
EMAIL: [email protected]
WEBSITE: https://millionpharma.com/osimeritinib-40mg.php
#Tagrisso #AstraZeneca #event #set #activity #Saudi #MCI #dinoboy #dnmgstudio #digitalnotions #vfx #films #content #cgi #DNMG #Studio #3D #animation #motiongraphics #mumbai #delhi #India #creative #design #digital #advertising #idea #concept https://lnkd.in/eHpVbzA https://www.instagram.com/p/BuY0AV8Hu3P/?utm_source=ig_tumblr_share&igshid=11abu97pykonp
#Tagrisso #AstraZeneca #event #set #activity #Saudi #MCI #dinoboy #dnmgstudio #digitalnotions #vfx #films #content #cgi #DNMG #Studio #3D #animation #motiongraphics #mumbai #delhi #India #creative #design #digital #advertising #idea #concept https://www.youtube.com/user/DNMGstudio (at Digital Notions Motion Graphics) https://www.instagram.com/p/BuRyT1qgdy1/?utm_source=ig_tumblr_share&igshid=k5opidoiwfmv
